本帖最后由 成长的烦恼 于 2012-6-27 20:19 编辑 / K" V0 P4 ~6 u5 G+ r7 {2 {+ n" a
$ f) G n0 N% H P
clinicaltrials上的三期临床链接
1 V+ g; J' w7 E9 D0 r
% W8 ]" A t5 f2 Dhttp://clinicaltrials.gov/ct2/sh ... mp;show_locs=Y#locn
* @) S& s' y v7 i, c6 P2 I/ d g# ^
中国参加临床实验的城市' T7 V8 K2 A ~/ ~8 |
, R" }9 E1 N1 H/ ?& m+ M! dChina, Guangdong 8 p$ b5 M% ~* D+ X; z
1 I7 d A) q* `( ?8 \, ^) |) CGuangzhou, Guangdong, China, 510515
+ W0 E% A t# I- o( k9 z2 @, ~# e( g
3 f- P# Y# I* F5 e: h! QGuangzhou, Guangdong, China, 510060 1 m/ x/ C# C) q* f. ~; v
China, Jiangsu
4 f: z' U* l( z9 g
1 s( B n8 n3 @Nanjing, Jiangsu, China, 210009 & c, a4 V% c0 O# U/ i o, S; {
/ D S2 y$ v$ W! b& h) F5 H. y
Nanjing, Jiangsu, China, 210002 - U4 D) B- X; j0 g7 B/ l
China, Shandong
' G( L3 V4 W% d
) N7 p' D$ t' gQingdao, Shandong, China, 266003 # m$ x C* a1 I5 u: k% [2 i) M
China 9 Q1 V2 ~- E4 f
# `2 Y* s( Y& O; j/ V6 EBeijing, China, 100021 . X# }+ _2 g1 B( J
( c3 V/ F M1 Z: XBeijing, China, 100071 ; s) J. m7 Q. W% n, _, W' f6 |8 W
9 R3 L: a9 L. {: \9 QChangchun, China, 130021
# x4 i; G+ V9 {) a# e; }
4 S$ T* G: L q! K' ^. q7 M8 iChongqing, China, 400042 : x1 U9 Y7 q: M, @' r& A H, ~
( _6 k5 \/ ^( [$ Y FChongqing, China, 400038
9 M* r; u9 S/ J. k& Q n
' [1 o3 s& X1 jFuzhou, China, 350014 / N7 w2 B& k/ z9 B/ W. Z. ]9 D/ X' ~
* e/ T$ T1 M& K$ C6 HFuzhou, China, 350025 + k/ B% s; \9 K4 o6 j1 U
5 S. y$ o- ^. K# _; ]6 E1 |! B* L
Ha'erbin, China, 150040 ( ~; B: D" H6 Q/ ~9 ]
; R% M/ y/ R, |Hanghzou, China, 310009
7 t R/ j$ S! v( l7 p& T % o+ _1 l* m8 S5 _* [' a! L2 [
Shanghai, China, 200001
+ b$ H8 W& [0 Q* _9 u z# [ & T. t: g) }% ?8 }
Shanghai, China, 200030
% z7 ~- P; F! p# `! h1 d! h
2 y. W1 n+ X) i: ^9 V8 PTianjin, China
! Q1 P% ?+ v' p% k+ P
. d3 ~# R7 E$ L6 u* T该实验已停止招募,重新开的临床请见临床专用贴。 |